Cargando…

Dry Powder Formulation of Simvastatin Nanoparticles for Potential Application in Pulmonary Arterial Hypertension

It has been hypothesized that simvastatin could be used to treat pulmonary arterial hypertension (PAH). This study is intended to formulate a simvastatin nanoparticle dry powder inhalation (DPI) formulation. Simvastatin nanoparticles were prepared via an emulsification and homogenization-extrusion m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zendehdel Baher, Shalaleh, Yaqoubi, Shadi, Asare-Addo, Kofi, Hamishehkar, Hamed, Nokhodchi, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145523/ https://www.ncbi.nlm.nih.gov/pubmed/35631481 http://dx.doi.org/10.3390/pharmaceutics14050895

Ejemplares similares

Carrier-Free Inhalable Dry Microparticles of Celecoxib: Use of the Electrospraying Technique
por: Jahangiri, Azin, et al.
Publicado: (2023)

Carrier Effect in Development of Rifampin Loaded Proliposome for Pulmonary Delivery: A Quality by Design Study
por: Parhizkar, Elahehnaz, et al.
Publicado: (2022)

Development of dry powder inhaler containing tadalafil-loaded PLGA nanoparticles
por: Varshosaz, Jaleh, et al.
Publicado: (2017)

The effect of different coating materials on the prevention of powder bounce in the next generation impactor
por: Khalili, Shadi Farshbaf, et al.
Publicado: (2018)

Aggregated Nanotransfersomal Dry Powder Inhalation of Itraconazole for Pulmonary Drug Delivery
por: Hassanpour Aghdam, Mehdi, et al.
Publicado: (2016)

Lectin Protein as a Promising Component to Functionalize Micelles, Liposomes and Lipid NPs against Coronavirus
por: Alavi, Mehran, et al.
Publicado: (2020)

Rapid releasing naproxen Liqui-Pellet using effervescent agent and neusilin US2
por: Lam, Matthew, et al.
Publicado: (2021)

Liqui-Tablet: the Innovative Oral Dosage Form Using the Newly Developed Liqui-Mass Technology
por: Lam, Matthew, et al.
Publicado: (2021)

Soyabean Powder as a Novel Diluent in Tablet Formulation of Simvastatin
por: Swami, G., et al.
Publicado: (2010)

Metronidazole- and Amoxicillin-Loaded PLGA and PCL Nanofibers as Potential Drug Delivery Systems for the Treatment of Periodontitis: In Vitro and In Vivo Evaluations
por: Mirzaeei, Shahla, et al.
Publicado: (2021)

Polyvinyl Alcohol/Chitosan Single-Layered and Polyvinyl Alcohol/Chitosan/Eudragit RL100 Multi-layered Electrospun Nanofibers as an Ocular Matrix for the Controlled Release of Ofloxacin: an In Vitro and In Vivo Evaluation
por: Mirzaeei, Shahla, et al.
Publicado: (2021)

Development of Solid Lipid Nanoparticles as Dry Powder: Characterization and Formulation Considerations
por: Santonocito, Debora, et al.
Publicado: (2023)

Development of a Spray-Dried Formulation of Peptide-DNA Nanoparticles into a Dry Powder for Pulmonary Delivery Using Factorial Design
por: Munir, Miftakul, et al.
Publicado: (2022)

Excipient Interactions in Glucagon Dry Powder Inhaler Formulation for Pulmonary Delivery
por: Rashid, Md Abdur, et al.
Publicado: (2019)

Puerarin dry powder inhaler formulations for pulmonary delivery: Development and characterization
por: Rashid, Md Abdur, et al.
Publicado: (2021)

Characterization of Amorphous and Co-Amorphous Simvastatin Formulations Prepared by Spray Drying
por: Craye, Goedele, et al.
Publicado: (2015)

Preparation of Poly-Lactic-Co-Glycolic Acid Nanoparticles in a Dry Powder Formulation for Pulmonary Antigen Delivery
por: Scherließ, Regina, et al.
Publicado: (2021)

Development and evaluation of Chitosan nanoparticles based dry powder inhalation formulations of Prothionamide
por: Debnath, Sujit Kumar, et al.
Publicado: (2018)

Simultaneous Spray Drying for Combination Dry Powder Inhaler Formulations
por: Shepard, Kimberly B., et al.
Publicado: (2022)

Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery
por: Zimmermann, Christoph M, et al.
Publicado: (2022)

Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis
por: Chennakesavulu, S., et al.
Publicado: (2018)

Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken design
por: Emami, J., et al.
Publicado: (2015)

Impact of Tablet Shape on Drug Dissolution Rate Through Immediate Released Tablets
por: Molavi, Fatima, et al.
Publicado: (2020)

Radiolabeling Method for Lyophilizate for Dry Powder Inhalation Formulations
por: Miyamoto, Kahori, et al.
Publicado: (2022)

Inhalable Nanoparticle-based Dry Powder Formulations for Respiratory Diseases: Challenges and Strategies for Translational Research
por: Chan, Ho Wan, et al.
Publicado: (2023)

A Critical Review on Emerging Trends in Dry Powder Inhaler Formulation for the Treatment of Pulmonary Aspergillosis
por: Cheng, Shen Nam, et al.
Publicado: (2020)

Recombinant Alpha-1 Antitrypsin as Dry Powder for Pulmonary Administration: A Formulative Proof of Concept
por: Bianchera, Annalisa, et al.
Publicado: (2022)

Performance Testing of a Homemade Aerosol Generator for Pulmonary Administration of Dry Powder Formulations to Mice
por: Heida, Rick, et al.
Publicado: (2023)

Co-spraying of carriers (mannitol-lactose) as a method to improve aerosolization performance of salbutamol sulfate dry powder inhaler
por: Ferdynand, Mickey Socrates, et al.
Publicado: (2020)

The Effect of Solvent Treatment on the Performance of Various Carriers in Dry Powder Inhalations Containing Salbutamol Sulphate
por: Siahai Shadbad, Mohammad Reza, et al.
Publicado: (2013)

Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation
por: Sibum, Imco, et al.
Publicado: (2019)

Spray Dried Formulations for Inhalation—Meaningful Characterisation of Powder Properties
por: Jüptner, Angelika, et al.
Publicado: (2019)

Simvastatin Solid Lipid Nanoparticles for Oral Delivery: Formulation Development and In vivo Evaluation
por: Padhye, S. G., et al.
Publicado: (2013)

Formulation and evaluation of simvastatin cubosomal nanoparticles for assessing its wound healing effect
por: Ahmed, Lamiaa M., et al.
Publicado: (2023)

Simvastatin, Sildenafil and Their Combination in Monocrotaline Induced Pulmonary Arterial Hypertension
por: Lee, Dong Seok, et al.
Publicado: (2010)

Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis Therapy
por: Shao, Zitong, et al.
Publicado: (2021)

Progress on Thin Film Freezing Technology for Dry Powder Inhalation Formulations
por: Pardeshi, Sagar R., et al.
Publicado: (2022)

Formulation and evaluation of simvastatin polymeric nanoparticles loaded in hydrogel for optimum wound healing purpose
por: Farghaly Aly, Usama, et al.
Publicado: (2019)

Pulmonary Delivery of an Ultra-Fine Oxytocin Dry Powder Formulation: Potential for Treatment of Postpartum Haemorrhage in Developing Countries
por: Prankerd, Richard J., et al.
Publicado: (2013)

Role of nanostructured lipid carriers in the expression alterations of ATP-binding cassette transporter genes in fluconazole-resistant Candida glabrata
por: Moazeni, Maryam, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_re70bbjv002sb4hrqi67p4v2fr